Molecular imaging using PET for breast cancer

被引：17

作者：

Kurihara, Hiroaki ^{[1
]}

Shimizu, Chikako ^{[2
]}

Miyakita, Yasuji ^{[3
]}

Yoshida, Masayuki ^{[4
]}

Hamada, Akinobu ^{[5
]}

Kanayama, Yousuke ^{[6
]}

Yonemori, Kan ^{[2
]}

Hashimoto, Jun ^{[2
]}

Tani, Hitomi ^{[1
]}

Kodaira, Makoto ^{[2
]}

Yunokawa, Mayu ^{[2
]}

Yamamoto, Harukaze ^{[2
]}

Watanabe, Yasuyoshi ^{[6
]}

Fujiwara, Yasuhiro ^{[2
]}

Tamura, Kenji ^{[2
]}

机构：

[1] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan

[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan

[3] Natl Canc Ctr, Dept Neurosurg, Tokyo 1040045, Japan

[4] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan

[5] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol Grp, Translat Res Support Core, Tokyo 104, Japan

[6] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan

来源：

BREAST CANCER | 2016年 / 23卷 / 01期

关键词：

Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2; POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; WHOLE-BODY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; F-18-FDG PET; TRASTUZUMAB; TUMOR; EXPRESSION;

D O I：

10.1007/s12282-015-0613-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.

引用

页码：24 / 32

页数：9

共 80 条

[61] FDG PET, PET/CT, and breast cancer imaging [J].

Rosen, Eric L. ;

Eubank, William B. ;

Mankoff, David A. .

RADIOGRAPHICS, 2007, 27 :S215-S229

[62] FLT:: Measuring tumor cell proliferation in vivo with positron emission tomography and 3′-Deoxy-3′-[18F]Fluorothymidine [J].

Salskov, Alexander ;

Tammisetti, Varaha S. ;

Grierson, John ;

Vesselle, Hubert .

SEMINARS IN NUCLEAR MEDICINE, 2007, 37 (06) :429-439

[63] Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy? [J].

Samson, DJ ;

Flamm, CR ;

Pisano, ED ;

Aronson, N .

ACADEMIC RADIOLOGY, 2002, 9 (07) :773-783

[64] Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations [J].

Sauter, Guido ;

Lee, James ;

Bartlett, John M. S. ;

Slamon, Dennis J. ;

Press, Michael F. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1323-1333

[65] Triple-Negative Breast Cancer: Risk Factors to Potential Targets [J].

Schneider, Bryan P. ;

Winer, Eric P. ;

Foulkes, William D. ;

Garber, Judy ;

Perou, Charles M. ;

Richardson, Andrea ;

Sledge, George W. ;

Carey, Lisa A. .

CLINICAL CANCER RESEARCH, 2008, 14 (24) :8010-8018

[66] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

[67] Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors [J].

Smith-Jones, PM ;

Solit, DB ;

Akhurst, T ;

Afroze, F ;

Rosen, N ;

Larson, SM .

NATURE BIOTECHNOLOGY, 2004, 22 (06) :701-706

[68] PET with [18F]fluorothymidine for imaging of primary breast cancer:: a pilot study [J].

Smyczek-Gargya, B ;

Fersis, N ;

Dittmann, H ;

Vogel, U ;

Reischl, G ;

Machulla, HJ ;

Wallwiener, D ;

Bares, R ;

Dohmen, BM .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (05) :720-724

[69]

Sorace AG, 2012, J ULTRAS MED, V31, P1543

[70] SEQUENTIAL ESTROGEN-RECEPTOR DETERMINATIONS FROM PRIMARY BREAST-CANCER AND AT RELAPSE - PROGNOSTIC AND THERAPEUTIC RELEVANCE [J].

SPATARO, V ;

PRICE, K ;

GOLDHIRSCH, A ;

CAVALLI, F ;

SIMONCINI, E ;

CASTIGLIONE, M ;

RUDENSTAM, CM ;

COLLINS, J ;

LINDTNER, J ;

GELBER, RD .

ANNALS OF ONCOLOGY, 1992, 3 (09) :733-740

← 1 2 3 4 5 6 7 8 →